UK markets close in 3 hours 14 minutes

Annovis Bio, Inc. (ANVS)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
9.85+0.86 (+9.57%)
At close: 04:00PM EDT
10.20 +0.35 (+3.55%)
Pre-market: 08:00AM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
17,823
38,791
16,516
8,479
3,054
Selling general and administrative
10,440
6,244
8,996
6,058
3,586
Total operating expenses
28,262
45,035
25,511
14,500
5,483
Operating income or loss
-28,262
-45,035
-25,511
-14,500
-5,483
Total other income/expenses net
-11,837
-11,837
-
-
-26.5
Income before tax
-28,148
-56,204
-25,329
-14,487
-5,462
Income from continuing operations
-28,148
-56,204
-25,329
-14,487
-5,462
Net income
-28,148
-56,204
-25,329
-14,487
-5,462
Net income available to common shareholders
-28,148
-56,204
-25,329
-14,487
-5,462
Basic EPS
-4.84
-
-3.10
-1.90
-0.87
Diluted EPS
-4.84
-
-3.10
-1.90
-0.87
Basic average shares
8,583
-
8,162
7,626
6,309
Diluted average shares
8,583
-
8,162
7,626
6,309